{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:07:00Z","timestamp":1792181220047,"version":"4.4.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2019.00180","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:47:42Z","timestamp":1559105262000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Bioactivity of Farnesyltransferase Inhibitors Against Entamoeba histolytica and Schistosoma mansoni"],"prefix":"10.3389","volume":"9","author":[{"given":"Alexandra","family":"Probst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi N.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"El-Sakkary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick S.","family":"Buckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Gelb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor R.","family":"Caffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjan","family":"Debnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e478","DOI":"10.1371\/journal.pntd.0000478","article-title":"Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening","volume":"3","author":"Abdulla","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/med.2610030204","article-title":"Praziquantel","volume":"3","author":"Andrews","year":"1983","journal-title":"Med. Res. Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1093\/bioinformatics\/btu831","article-title":"The QDREC web server: determining dose-response characteristics of complex macroparasites in phenotypic drug screens","volume":"31","author":"Asarnow","year":"2015","journal-title":"Bioinformatics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2174\/1389557518666180801110342","article-title":"Farnesyl transferase inhibitors as potential anticancer agents","volume":"18","author":"Bagchi","year":"2018","journal-title":"Mini Rev. Med. Chem."},{"key":"B5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2307\/3280632","article-title":"Cultivation of Schistosoma mansoni in vitro. I. Establishment of cultures from cercariae and development until pairing","volume":"67","author":"Basch","year":"1981","journal-title":"J. Parasitol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1038\/emm.2013.30","article-title":"G protein signaling in the parasite Entamoeba histolytica","volume":"45","author":"Bosch","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0166-6851(02)00099-3","article-title":"Cloning, heterologous expression, and substrate specificities of protein farnesyltransferases from Trypanosoma cruzi and Leishmania major","volume":"122","author":"Buckner","year":"2002","journal-title":"Mol. Biochem. Parasitol."},{"key":"B8","first-page":"791","article-title":"Protein farnesyl transferase inhibitors for the treatment of malaria and African trypanosomiasis","volume":"6","author":"Buckner","year":"2005","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"B9","doi-asserted-by":"publisher","first-page":"21870","DOI":"10.1074\/jbc.M000975200","article-title":"Cloning, heterologous expression, and distinct substrate specificity of protein farnesyltransferase from Trypanosoma brucei","volume":"275","author":"Buckner","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cbpa.2007.05.031","article-title":"Chemotherapy of schistosomiasis: present and future","volume":"11","author":"Caffrey","year":"2007","journal-title":"Curr. Opin. Chem. Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.4155\/fmc.15.27","article-title":"Schistosomiasis and its treatment","volume":"7","author":"Caffrey","year":"2015","journal-title":"Fut. Med. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6517","DOI":"10.1016\/j.bmc.2004.09.020","article-title":"In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability","volume":"12","author":"Carrico","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"42066","DOI":"10.1074\/jbc.M202860200","article-title":"Protein farnesyltransferase and protein prenylation in Plasmodium falciparum","volume":"277","author":"Chakrabarti","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"B15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"key":"B16","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/nm.2758","article-title":"A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target","volume":"18","author":"Debnath","year":"2012","journal-title":"Nat. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1128\/AAC.02576-14","article-title":"Hsp90 inhibitors as new leads to target parasitic diarrheal diseases","volume":"58","author":"Debnath","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0035-9203(78)90144-X","article-title":"A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba","volume":"72","author":"Diamond","year":"1978","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"B19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/31.1.9","article-title":"Nitroimidazole drugs\u2013action and resistance mechanisms. I. Mechanisms of action","volume":"31","author":"Edwards","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"B20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev.biochem.68.1.157","article-title":"Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway","volume":"68","author":"Edwards","year":"1999","journal-title":"Annu. Rev. Biochem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1004666","DOI":"10.1371\/journal.ppat.1004666","article-title":"Small GTPase Rab21 mediates fibronectin induced actin reorganization in Entamoeba histolytica: implications in pathogen invasion","volume":"11","author":"Emmanuel","year":"2015","journal-title":"PLoS Pathog."},{"key":"B22","doi-asserted-by":"publisher","first-page":"7186","DOI":"10.1021\/jm050456x","article-title":"Benzophenone-based farnesyltransferase inhibitors with high activity against Trypanosoma cruzi","volume":"48","author":"Esteva","year":"2005","journal-title":"J. Med. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1124\/pr.111.004994","article-title":"Pharmacological actions of statins: a critical appraisal in the management of cancer","volume":"64","author":"Gazzerro","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"10873","DOI":"10.3390\/molecules200610873","article-title":"Anti-schistosomal activity of cinnamic acid esters: eugenyl and thymyl cinnamate induce cytoplasmic vacuoles and death in schistosomula of Schistosoma mansoni","volume":"20","author":"Glaser","year":"2015","journal-title":"Molecules"},{"key":"B25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.116.022188","article-title":"Clinical trial of the protein farnesylation inhibitors lonafarnib, pravastatin, and zoledronic acid in children with hutchinson-gilford progeria syndrome","volume":"134","author":"Gordon","year":"2016","journal-title":"Circulation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1001\/jama.2018.3264","article-title":"Association of Lonafarnib treatment vs no treatment with mortality rate in patients with Hutchinson-Gilford Progeria syndrome","volume":"319","author":"Gordon","year":"2018","journal-title":"JAMA"},{"key":"B28","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nri1839","article-title":"Statin therapy and autoimmune disease: from protein prenylation to immunomodulation","volume":"6","author":"Greenwood","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1056\/NEJMra022710","article-title":"Amebiasis","volume":"348","author":"Haque","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/bs.apar.2018.03.002","article-title":"Human parasitology and parasitic diseases: heading towards 2050","volume":"100","author":"Hotez","year":"2018","journal-title":"Adv. Parasitol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1172\/JCI34261","article-title":"Helminth infections: the great neglected tropical diseases","volume":"118","author":"Hotez","year":"2008","journal-title":"J. Clin. Invest."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/S0020-7519(01)00268-5","article-title":"Identification and characterisation of Toxoplasma gondii protein farnesyltransferase","volume":"31","author":"Ibrahim","year":"2001","journal-title":"Int. J. Parasitol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.actatropica.2009.11.012","article-title":"Parasites and poverty: the case of schistosomiasis","volume":"113","author":"King","year":"2010","journal-title":"Acta Trop."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1021\/jm9013136","article-title":"Second generation analogues of the cancer drug clinical candidate tipifarnib for anti-Chagas disease drug discovery","volume":"53","author":"Kraus","year":"2010","journal-title":"J. Med. Chem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1021\/jm801313t","article-title":"Rational modification of a candidate cancer drug for use against Chagas disease","volume":"52","author":"Kraus","year":"2009","journal-title":"J. Med. Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1074\/jbc.M311478200","article-title":"Molecular cloning and characterization of a protein farnesyltransferase from the enteric protozoan parasite Entamoeba histolytica","volume":"279","author":"Kumagai","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1371\/journal.pbio.0050211","article-title":"Nitroimidazole action in Entamoeba histolytica: a central role for thioredoxin reductase","volume":"5","author":"Leitsch","year":"2007","journal-title":"PLoS Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1003665","DOI":"10.1371\/journal.ppat.1003665","article-title":"Toxoplasma gondii relies on both host and parasite isoprenoids and can be rendered sensitive to atorvastatin","volume":"9","author":"Li","year":"2013","journal-title":"PLoS Pathog."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0004356","DOI":"10.1371\/journal.pntd.0004356","article-title":"Structure-bioactivity relationship for benzimidazole thiophene inhibitors of polo-like kinase 1 (PLK1), a potential drug target in Schistosoma mansoni","volume":"10","author":"Long","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"B41","first-page":"303","article-title":"Farnesyltransferase inhibition in hematologic malignancies: the clinical experience with tipifarnib","volume":"6","author":"Martinelli","year":"2008","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e1007116","DOI":"10.1371\/journal.ppat.1007116","article-title":"De novo biosynthesis of sterols and fatty acids in the Trypanosoma brucei procyclic form: carbon source preferences and metabolic flux redistributions","volume":"14","author":"Millerioux","year":"2018","journal-title":"PLoS Pathog."},{"key":"B43","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.2174\/09298673113206660262","article-title":"Farnesyltransferase inhibitors: a comprehensive review based on quantitative structural analysis","volume":"20","author":"Moorthy","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"B44","first-page":"165","article-title":"Mode of action of metronidazole on anaerobic bacteria and protozoa","volume":"93","author":"Muller","year":"1983","journal-title":"Surgery"},{"key":"B45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0166-6851(99)00029-8","article-title":"Characterization of the Ras homologue of Schistosoma mansoni","volume":"100","author":"Osman","year":"1999","journal-title":"Mol. Biochem. Parasitol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1369-5274(02)00335-1","article-title":"Pathogenesis of amebiasis","volume":"5","author":"Petri","year":"2002","journal-title":"Curr. Opin. Microbiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/313493","article-title":"Diagnosis and management of amebiasis","volume":"29","author":"Petri","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e87594","DOI":"10.1371\/journal.pone.0087594","article-title":"Chemical and genetic validation of the statin drug target to treat the helminth disease, schistosomiasis","volume":"9","author":"Rojo-Arreola","year":"2014","journal-title":"PLoS ONE"},{"key":"B49","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/jac\/40.6.833","article-title":"Involvement of superoxide dismutase and pyruvate:ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica","volume":"40","author":"Samarawickrema","year":"1997","journal-title":"J. Antimicrob. Chemother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S0140-6736(03)12830-9","article-title":"Amoebiasis","volume":"361","author":"Stanley","year":"2003","journal-title":"Lancet"},{"key":"B51","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/01.qco.0000092821.42392.ca","article-title":"Entamoeba histolytica: an update","volume":"16","author":"Stauffer","year":"2003","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e850","DOI":"10.1371\/journal.pntd.0000850","article-title":"RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening","volume":"4","author":"\u0160tefani\u0107","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1016\/j.actatropica.2010.08.020","article-title":"From innovation to application: social-ecological context, diagnostics, drugs and integrated control of schistosomiasis","volume":"120","author":"Utzinger","year":"2011","journal-title":"Acta Trop."},{"key":"B54","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.molmed.2007.11.004","article-title":"Pleiotropic effects of statin therapy: molecular mechanisms and clinical results","volume":"14","author":"Wang","year":"2008","journal-title":"Trends Mol. Med."},{"key":"B55","doi-asserted-by":"crossref","first-page":"26051","DOI":"10.1074\/jbc.274.37.26051","article-title":"Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase","volume":"274","author":"Wassmann","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B56","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/mmi.13131","article-title":"Molecular biology research to benefit patients with Entamoeba histolytica infection","volume":"98","author":"Watanabe","year":"2015","journal-title":"Mol. Microbiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/s41598-017-18457-w","article-title":"Sertraline, Paroxetine, and Chlorpromazine Are Rapidly Acting Anthelmintic Drugs Capable of Clinical Repurposing","volume":"8","author":"Weeks","year":"2018","journal-title":"Sci. Rep."},{"key":"B58","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1146\/annurev.bi.65.070196.001325","article-title":"Protein prenylation: molecular mechanisms and functional consequences","volume":"65","author":"Zhang","year":"1996","journal-title":"Annu. Rev. Biochem."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2019.00180\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:47:47Z","timestamp":1559105267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2019.00180\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,29]]},"references-count":58,"alternative-id":["10.3389\/fcimb.2019.00180"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2019.00180","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,29]]},"article-number":"180"}}